CIBC Private Wealth Group
ORKA

CIBC Private Wealth Group’s Oruka Therapeutics ORKA Stock Holding History

CIBC Private Wealth Group’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$30 Hold
1
– – ﹤0.01% 3349
2025
Q3 		$19 Buy
+1
New +$15 ﹤0.01% 3050

Other funds holding ORKA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

CIBC Private Wealth Group's ORKA Position: Q4 2025 in Review

CIBC Private Wealth Group held its Oruka Therapeutics (ORKA) position steady in Q4 2025 at 1 share worth $30. The position accounts for ﹤0.01% of the portfolio, ranked #3349.

CIBC Private Wealth Group first reported a position in ORKA in Q3 2025 and has held it in 2 quarters since. 143 funds tracked by Wall St. Rank hold ORKA as of Q4 2025.

  • CIBC Private Wealth Group held 1 share of Oruka Therapeutics worth $30 as of Q4 2025.
  • CIBC Private Wealth Group left its Oruka Therapeutics share count unchanged in Q4 2025.
  • Oruka Therapeutics made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #3349 holding.
  • CIBC Private Wealth Group first reported a position in Oruka Therapeutics in Q3 2025 and has held it in 2 quarters since.
  • 143 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.